Clinical Trial Update: Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety, tolerability, PK, and activity of topical ATx201 Gel in outpatients with impetigo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impetigo

Drugs mentioned

• ATx201 Gel (ATx201)

Snippet

Sponsor: UNION therapeutics | Conditions: Impetigo | Phase 2 | Status: COMPLETED